HIGH TECH PHARM (106190) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, HIGH TECH PHARM (106190) reported revenue of 70.2 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202570.2 billion KRW12.9 billion KRW11.5 billion KRW[source]
202477.5 billion KRW15.6 billion KRW13.7 billion KRW[source]
202376.8 billion KRW10.1 billion KRW8.1 billion KRW[source]
2022102.9 billion KRW4.9 billion KRW5.9 billion KRW[source]
202173.3 billion KRW-412 million KRW-1.2 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025143.7 billion KRW13.0 billion KRW130.7 billion KRW[source]
2024140.1 billion KRW20.4 billion KRW119.7 billion KRW[source]
2023135.1 billion KRW28.1 billion KRW107.0 billion KRW[source]
2022132.2 billion KRW32.3 billion KRW99.9 billion KRW[source]
2021122.9 billion KRW29.1 billion KRW93.9 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice